Single Injection Appears to Prevent Virtually All Allergic Reactions

Image by H. Armstrong / Debrocke / ClassicStock via Getty / Futurism Developments We could be nearing a cure for those nasty spring allergies — and even allergic reactions altogether. A decades-old asthma medication called omalizumab, which is sold as Xolair, has shown that it can successfully treat seasonal allergies in preliminary clinical trials. Administered as a single injection, it represents a type of treatment using lab-made proteins known as monoclonal antibodies, which can cut off your body's allergic response at its source. So whether it's pollen or peanuts bothering you, it's got you covered. "The biggest advantage of antibody-based therapeutics is that they offer the potential to target the underlying pathways driving allergic reactions in general," Sayantani Sindher, a clinical associate professor at Stanford University's Sean N. Parker Center for Allergy and Asthma Research, told Vox. "This means antibody-based therapies will simultaneously impact all of the patient's ... Read full article.